Medicinal composition

Details for Australian Patent Application No. 2005283422 (hide)

Owner Eisai R & D Management Co., Ltd.

Inventors Furitsu, Hisao; Suzuki, Yasuyuki

Agent Davies Collison Cave

Pub. Number AU-B-2005283422 (Modified Examination)

PCT Pub. Number WO2006/030826

Priority 2004-272625 17.09.04 JP

Filing date 14 September 2005

Wipo publication date 23 March 2006

Acceptance publication date 13 May 2010

International Classifications

A61K 31/47 (2006.01) - Quinolines

A61K 47/04 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 215/48 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/030826 Priority application(s): WO2006/030826

13 May 2010 Application Accepted

  Published as AU-B-2005283422 (Modified Examination)

5 August 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 08 Jul 2010. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

25 November 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 08 Jul 2010

2 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005283435-Capsule-type endoscope

2005283330-Carbohydrase inhibitors derived from chestnut and use thereof